NewEdge Advisors’s Alimera Sciences ALIM Stock Holding History
Bought
Maintained
Sold
NewEdge Advisors's ALIM Position: Q3 2024 in Review
NewEdge Advisors sold out of Alimera Sciences (ALIM) in Q3 2024, closing a stake of 2 shares — an estimated $12 sold.
NewEdge Advisors first reported a position in ALIM in Q2 2024 and held it in 1 quarter. The position peaked at $12 in Q2 2024. 0 funds tracked by Wall St. Rank hold ALIM as of Q3 2024.
- NewEdge Advisors reported no remaining Alimera Sciences position as of Q3 2024 after selling out during the quarter.
- NewEdge Advisors sold 2 Alimera Sciences shares in Q3 2024, an estimated $12.
- NewEdge Advisors first reported a position in Alimera Sciences in Q2 2024 and held it in 1 quarter.
- NewEdge Advisors's Alimera Sciences position peaked at $12 in Q2 2024.
- 0 funds tracked by Wall St. Rank held Alimera Sciences as of Q3 2024.
Based on NewEdge Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.